Correlation between hMLH1/hMSH2 and p53 protein expression in sporadic colorectal cancer

Hepato-Gastroenterology

Volumn 52, Issue 62, 2005, Pages 450-454

  Park, In J ^a   Kim, Hee Cheol ^a   Kim, Jung S ^a   Yu, Eun S ^a   Yu, Chang S ^a   Kim, Jin C ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Colorectal neoplasm; hMLH1; hMSH2; Immunohistochemistry; p53

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN MLH1; PROTEIN MSH2; PROTEIN P53;

ADULT; CELL TYPE; CLINICAL FEATURE; COLORECTAL CANCER; CORRELATION ANALYSIS; FAMILY HISTORY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MULTIVARIATE ANALYSIS; PARAMETER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETROSPECTIVE STUDY; REVIEW;

CARRIER PROTEINS; COLORECTAL NEOPLASMS; DNA-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; STAINING AND LABELING; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 16344363017     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Farber E: Cancer development and its natural history. A cancer prevention perspective. Cancer 1988; 62:1676-1679.
2. Lengauer C, Kinzler KW, Vogelstein B: Genetic instabilities in human cancers. Nature 1998; 396:643-649.
3. Loeb LA: Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 1991; 51:3075-3079.
4. Aaltonen LA, Peltomaki P, Leach FS, et al: Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260:812-816.
5. Liu B, Parsons R, Papadopoulos N, et al: Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 1996; 2:169-174.
6. Bapat BV, Madlensky L, Temple LK, et al: Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer. Hum Genet 1999; 104:167-176.
7. Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 1996; 87:159-170.
8. Herman JG, Umar A, Polyak K, et al: Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 1998; 95:6870-6875.
9. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-767.
10. Samowitz WS, Holden JA, Curtin K, et al: Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer. Am J Pathol 2001; 158:1517-1524.
11. Breivik J, Lothe RA, Meling GI, et al: Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int J Cancer 1997; 74:664-669.
12. Gryfe R, Kim H, Hsieh ET, et al: Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000; 342:69-77.
13. Hemminki A, Mecklin JP, Jarvinen H, et al: Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterol 200; 119:921-928.
14. Lamberti C, Kruse R, Ruelfs C, et al: Microsatellite instability-a useful diagnostic tool to select patients at high risk for hereditary non-polyposis colorectal cancer: a study in different groups of patients with colorectal cancer. Gut 1999; 44:839-843.
15. Chaves P, Cruz C, Lage P, et al: Immunohistochemical detection of mismatch repair gene proteins as a useful tool for the identification of colorectal carcinoma with the mutator phenotype. J Pathol 2000; 191:355-360.
16. Kim H, Piao Z, Kim JW, et al: Expression of hMSH2 and hMLH1 in colorectal carcinomas with microsatellite instability. Pathol Res Pract 1998; 194:3-9.
17. Salahshor S, Koelble K, Rubio C, et al: Microsatellite instability and hMLH1 and hMSH2 expression analysis in familial and sporadic colorectal cancer. Lab Invest 2001; 81:535-541.
18. Hendriks Y, Franken P, Dierssen JW, et al: Conventional and immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors. Am J Pathol 2003; 162:469-477.
19. Wahlberg SS, Schmeits J, Thomas G, et al: Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Res 2002; 62:3485-3492.
20. Baas IO, Mulder JW, Offerhaus GJ, et al: An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994; 172:5-12.
21. Ilyas M, Straub J, Tomlinson IP, Bodmer WF: Genetic pathways in colorectal and other cancers. Eur J Cancer 1999; 35:1986-2002.
22. Boland CR, Thibodeau SN, Hamilton SR, et al: A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58:5248-5257.
23. Konishi M, Kikuchi-Yanoshita R, Tanaka K, et al: Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 1996; 111:307-317.
24. Fishel R: The selection for mismatch repair defects in hereditary nonpolyposis colorectal cancer: revising the imitator hypothesis. Cancer Res 2001; 61:7369-7374.
25. Blackwell LJ, Martik D, Bjornson KP, et al: Nucleotide-promoted release of hMutSalpha from heteroduplex DNA is consistent with an ATP-dependent translocation mechanism. J Biol Chem 1998; 273:32055-32062.
26. Lynch HT, Smyrk T: An update on Lynch syndrome. Curr Opin Oncol 1998; 10:349-356.
27. Lin X, Ramamurthi K, Mishima M, et al: P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin. Cancer Res 2001; 61:1508-1516.